|
|
|
Insider
Information: |
Webster Stephen W |
Relationship: |
|
City: |
Exton |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
44,447 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$440,218 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
44,447 |
|
|
Total
Value |
$440,218 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Adolor Corp |
ADLR |
SVP, Finance & CFO |
2011-12-12 |
0 |
2009-12-15 |
0 |
Premium* |
|
Optimer Pharmaceuticals Inc |
OPTR |
Chief Financial Officer |
2013-10-24 |
0 |
2012-06-29 |
0 |
Premium* |
|
Spark Therapeutics, Inc. |
ONCE |
CHIEF FINANCIAL OFFICER |
2019-12-17 |
0 |
2015-02-04 |
0 |
Premium* |
|
Nabriva Therapeutics AG |
NBRV |
Director |
2022-08-02 |
11,447 |
2018-05-23 |
0 |
Premium* |
|
Viking Therapeutics, Inc. |
VKTX |
Director |
2018-05-29 |
8,000 |
2018-05-29 |
0 |
Premium* |
|
Gritstone Oncology, Inc. |
GRTS |
|
2024-04-26 |
25,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GRTS |
Gritstone Oncology, Inc. |
|
|
2024-04-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
% |
|
ADLR |
Adolor Corp |
SVP Finance & CFO |
|
2009-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
45,000 |
0 |
- |
|
ADLR |
Adolor Corp |
SVP, Finance & CFO |
|
2010-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
82,500 |
127,500 |
0 |
- |
|
ADLR |
Adolor Corp |
SVP, Finance & CFO |
|
2011-06-27 |
4 |
B |
$1.88 |
$18,800 |
D/D |
10,000 |
137,500 |
2.74 |
- |
|
ADLR |
Adolor Corp |
SVP, Finance & CFO |
|
2011-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
13,750 |
151,250 |
0 |
- |
|
ADLR |
Adolor Corp |
SVP, Finance & CFO |
|
2011-12-12 |
4 |
OE |
$1.34 |
$200,000 |
D/D |
130,000 |
281,250 |
0 |
- |
|
ADLR |
Adolor Corp |
SVP, Finance & CFO |
|
2011-12-12 |
4 |
D |
$4.25 |
$1,195,313 |
D/D |
(281,250) |
0 |
0 |
- |
|
OPTR |
Optimer Pharmaceuticals I... |
CFO |
|
2012-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
0 |
- |
|
OPTR |
Optimer Pharmaceuticals I... |
Chief Financial Officer |
|
2013-10-24 |
4 |
D |
$10.75 |
$268,750 |
D/D |
(25,000) |
0 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2015-02-04 |
4 |
B |
$23.00 |
$57,500 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2015-10-07 |
4 |
S |
$48.86 |
$977,200 |
D/D |
(20,000) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2015-10-07 |
4 |
OE |
$3.45 |
$69,000 |
D/D |
20,000 |
22,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2016-05-20 |
4 |
OE |
$3.45 |
$69,000 |
D/D |
20,000 |
22,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2016-05-20 |
4 |
S |
$50.38 |
$1,007,820 |
D/D |
(20,000) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-04-24 |
4 |
AS |
$55.00 |
$104,390 |
D/D |
(1,898) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-04-24 |
4 |
OE |
$3.45 |
$6,548 |
D/D |
1,898 |
4,398 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-04-25 |
4 |
OE |
$3.45 |
$27,952 |
D/D |
8,102 |
10,602 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-04-25 |
4 |
AS |
$55.22 |
$447,392 |
D/D |
(8,102) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-06-19 |
4 |
AS |
$60.00 |
$459,780 |
D/D |
(7,663) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-06-19 |
4 |
OE |
$3.45 |
$26,437 |
D/D |
7,663 |
10,163 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-07-31 |
4 |
OE |
$3.45 |
$8,063 |
D/D |
2,337 |
4,837 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-07-31 |
4 |
AS |
$71.12 |
$166,207 |
D/D |
(2,337) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-08-15 |
4 |
AS |
$79.38 |
$793,800 |
D/D |
(10,000) |
2,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-08-15 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
12,500 |
0 |
- |
|
ONCE |
Spark Therapeutics, Inc. |
Chief Financial Officer |
|
2017-11-16 |
4 |
OE |
$3.45 |
$34,500 |
D/D |
10,000 |
12,500 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|